Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Thyroid Nodule 1Thyroid Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinoma, Lobular 1COVID-19 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Tamoxifen 2Neoadjuvant Therapy 2Early Intervention, Educational 2Vinorelbine 1Trastuzumab 1Therapeutics 1Radiotherapy 1Radiation Dose Hypofractionation 1Psychiatric Rehabilitation 1Molecular Diagnostic Techniques 1Methods 1Meditation 1Mastectomy, Segmental 1Hypnosis 1Gene Expression Profiling 1Fulvestrant 1Epirubicin 1Educational Status 1Docetaxel 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Capecitabine 1Bevacizumab 1Anastrozole 1Analgesia 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Carcinoma In Situ × Molecular Diagnostic Techniques × Clear all
NCT00536718 2013-08-12

Genetics of Women With Lobular Carcinoma in Situ of the Breast

National Cancer Institute (NCI)

Unknown
3,000 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡